Search Results - "Phillips, Kynlon"

Posaconazole versus voriconazole as antifungal prophylaxis during induction therapy for acute myelogenous leukemia or myelodysplastic syndrome by Phillips, Kynlon, Cirrone, Frank, Ahuja, Tania, Siegfried, Justin, Papadopoulos, John

“…Objective Patients with acute myelogenous leukemia or myelodysplastic syndrome undergoing induction chemotherapy are at increased risk of invasive fungal…”
Get full text

Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient by Schweiger, Jennifer, Phillips, Kynlon, Patel, Arpita, Echols, Carmen

Get full text

Repurposing of antiangiogenic agents for treatment of vascular anomalies by Blatt, Julie, Brondon, Jennifer E., Nieman, Elizabeth L., Phillips, Kynlon, Pandya, Arti

“…Vascular anomalies (VA) are developmental anomalies of veins, arteries, lymphatics or capillaries thought to be caused by mutations in genes that drive…”
Get full text

Use of allopurinol to manage skewed 6‐mercaptopurine metabolism in pediatric maintenance acute lymphoblastic leukemia treatment by Lines, Mandee, Kemper, Ryan M., Wallace, Jordan, Alexander, Thomas, Echols, Carmen, Garner, Lauren M., Kaplan, Jenna Bognaski, Thompson, Patrick, Crona, Daniel J., Phillips, Kynlon

“…Background 6‐mercaptopurine is a cornerstone of maintenance therapy for pediatric ALL. Response to 6MP is typically determined by the ANC. Therapeutic ANC…”
Get full text

Medication Desensitization: Single Intravenous Bag Method, in 3 Pediatric Patients by Wallace, Jordan, Garner, Lauren, Echols, Carmen, Phillips, Kynlon, Kaplan, Jenna Bognaski

“…Chemotherapies and biologic agents are known to cause hypersensitivity reactions (HSRs). It is imperative that pediatric patients receive these agents to treat…”
Get full text